Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
Primary Relief
DyAnsys' neurostimulation device receives FDA clearance to treat post-cardiac surgery pain
By
Jessica Hagen
|
01:54 pm |
September 27, 2022
The company’s device, Primary Relief, is the latest of DyAnsys’ long list of devices to receive FDA clearance.